Stock Price
4.64
Daily Change
-0.08 -1.59%
Monthly
13.33%
Yearly
85.27%
Q1 Forecast
4.59

EDAP TMS reported EUR34.12M in Current Liabilities for its fiscal quarter ending in June of 2025.





Current Liabilities Change Date
AngioDynamics USD 77.97M 10.62M Feb/2025
Boston Scientific USD 5.44B 111M Dec/2025
EDAP TMS EUR 34.12M 562K Jun/2025
Henry Schein USD 3.15B 142M Sep/2025
Medtronic USD 9.94B 1.6B Sep/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Veracyte USD 72.15M 4.28M Sep/2025